Fraud scandal at the district court: Cancer patients deceived for money!

Fraud scandal at the district court: Cancer patients deceived for money!

At the Düsseldorf district court, a process begins that shows the abysses of the healthcare system. Five defendants, including four men between the ages of 50 and 64 and a 67-year-old woman, have to answer for an incurable person for suspected fraud. T-Online reports that the accused of the 32-year-old, who suffers from a total of 95,000 euros Effective therapies are said to have decreased.

The man who was considered to be exhausted was addressed by a 50-year-old accused from Cologne, who promised him "very good chances of recovery" and an "80 percent rate of success". The patient claimed the supposed help and received an injection in March 2019, which was referred to as "personalized immune therapy", as well as light therapy. Unfortunately, however, there was no improvement in his health, and the patient died only three days after the treatment. According to Kölner Stadt-Anzeiger , the main accused of the deceased later reimbursed 19,000 euros.

serious allegations and legal consequences

The accused face serious allegations, including violations of the alternative practitioner law, dangerous bodily harm and fraud. The fact that none of the accused has a qualification as a doctor or alternative practitioner is particularly alarming. This raises questions about security and ethics in the health sector.

The process begins on Friday at 10 a.m. and is already the fourth attempt on this matter, which underlines the tragedy and complexity of the case. Such cases are unfortunately part of a worrying trend that caused the statutory health insurance companies to draw attention to fraud in the healthcare sector. Tagesschau reports that the perpetrators use more complex structures to illegally get money last year, which led to a record amount of over 200 million euros in exposed fraud.

The indictment and the rest of the procedure could have far -reaching consequences, not only for the accused, but also for regulation and surveillance in healthcare. The case asks the question of how such frauds can be better prevented in the future in order to avoid suffering and loss of similar nature.